Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Transplant Proc ; 52(10): 3186-3191, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32646585

ABSTRACT

INTRODUCTION: In this study,we investigated the presence of cytomegalovirus (CMV) infection in kidney transplanted children and its effect on kidney dysfunction. MATERIAL AND METHODS: One hundred thirty-five pediatric renal transplant patients were included in this study. The presence of CMV infection, CMV risk status, and other clinical features of the patients were evaluated retrospectively. RESULTS: Fifty-three percent of all patients and 68.8% of patients with CMV were male. The mean age was 12 years in all patients and CMV groups. According to the CMV risk classification, 40.9% of the patients with CMV infection/disease were in the high-risk group (CMV D+R-). In CMV risk groups, the presence of CMV infection/disease was similar. Cold ischemia time, male sex (patients and donors), deceased donor, higher HLA-mismatches, and cumulative antithymocyte globulin dose were found as risk factors for CMV infection/disease. Acute rejection/graft failure was observed in 27% of all patients. CMV infection has no effect on rejection/graft failure and survival. DISCUSSION: The frequency and risk factors of CMV in renal transplant children in our study were consistent with the literature. CONCLUSIONS: CMV infection was found in one-fifth of our patients and the majority (71.9%) of them developed infection in the first 6 months. In one-third of our patients acute rejection/graft failure was observed. There was no effect of CMV infection on rejection/graft failure and survival in pediatric patients with proper and effective treatment.


Subject(s)
Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/immunology , Immunocompromised Host , Kidney Transplantation , Postoperative Complications/virology , Antiviral Agents/therapeutic use , Child , Cytomegalovirus/immunology , Cytomegalovirus Infections/drug therapy , Female , Graft Rejection/virology , Humans , Male , Postoperative Complications/immunology , Retrospective Studies , Risk Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...